# Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).

> **NCT06297512** · PHASE2 · RECRUITING · sponsor: **Iacopo Sardi** · enrollment: 20 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** Radiotherapy, Temozolomide, Doxorubicin

## Key facts

- **NCT ID:** NCT06297512
- **Lead sponsor:** Iacopo Sardi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-09
- **Primary completion:** 2027-11-09
- **Final completion:** 2028-03-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06297512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06297512, "Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06297512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*